The plasma membrane microdomains, lipid rafts, are involved in regulation of cellular functions such as cell survival and adhesion. Cholesterol is a critical component of lipid rafts in terms of their integrity and functions and rafts disruption by cholesterol depletion can induce detachment-induced cell death. Hypoxia inducible factor-1 (HIF-1) a is stabilized in hypoxia and transactivates numerous genes required for cellular adaptation to hypoxia. It is also induced by non-hypoxic stimuli and contributes to cell survival. Because hypoxia inhibits cholesterol synthesis and HIF-1a plays a role in this process, we here explored a possible connection between lipid rafts and HIF-1a. We investigated whether HIF1a is regulated during cholesterol depletion/rafts disruption in A431 cells in normoxic conditions. Methyl-beta cyclodextrin (MbCD), which induces cholesterol depletion, upregulated HIF1a even under normoxic conditions and this upregulation required epidermal growth factor receptor (EGFR) and extracellular signal-regulated kinase 1 and 2 activation, but not Akt activation. MbCD treatment induced HIF-1a upregulation at both the transcriptional and translational levels but not at the posttranslational levels. In addition, MbCD robustly induced vascular endothelial growth factor production and stimulated an hypoxia response element-driven luciferase reporter activity under normoxic conditions, indicating that MbCD-induced HIF-1a is functionally activated. Both EGFR activity and HIF-1a expression were higher in the attached cells than in the detached cells after MbCD treatment. Furthermore, inhibition of HIF-1a by RNA interference accelerated cell detachment, thus increasing cell death, indicating that HIF-1a expression attenuates MbCDinduced anoikis-like cell death. These data suggest that, depending on cholesterol levels, lipid rafts or membrane fluidity are probably to regulate HIF-1a expression in normoxia by modulating rafts protein activities such as EGFR, and this connection between lipid rafts and HIF-1a regulation may provide cell survival under membrane-disturbing stress.
Introduction
Lipid rafts/caveolae are distinct cholesterol and sphingolipid-rich microdomains of the plasma membrane. Caveolae are a subset of rafts that are characterized by flask-like invaginations in cells expressing caveolin-1 (1) (2) (3) . Rafts are enriched in proteins involved in transmembrane signal transduction in various cell types (3) . Many receptors, including epidermal growth factor receptor (EGFR), Fas and the integrins are present in rafts, thereby rendering these membrane structures pivotal in the regulation of cell proliferation, death, adhesion and motility (3) . Cholesterol is a critical lipid component for rafts integrity, and disruption of rafts by cholesterol depletion impairs a number of signal transduction pathways and results in deregulation of biological functions (1, 2) . For example, we have demonstrated recently that cholesterol depletion induced a decrease in cell surface lipid rafts levels and cell detachment-induced cell death, indicating that the integrity and/or levels of rafts on the cell surface is essential for cell adhesion and survival (4) .
Increasing evidence emphasizes that cholesterol levels are associated with tumor incidence and malignancy. A hospital-based casecontrol study has revealed that high levels of serum cholesterol correlate with the increased risk of prostate cancer (5) . Interestingly, cholesterol and other fatty acid deposits accumulate in solid tumors and increased cholesterol levels have been associated with elevated levels of rafts in the plasma membrane (4, 6) . In cancer cells, cholesterol accumulation might expand lipid rafts in which signals are processed that are essential to cell proliferation and cell survival (6) .
The cellular cholesterol level is tightly regulated either through supply via endocytosis of low-density lipoprotein or de novo synthesis of cholesterol. The enzyme, 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase, is the rate-limiting enzyme of cholesterol synthesis. Synthesis of one molecule of cholesterol from one molecule of acetylCoA requires 11 molecules of O 2 , indicating that this process is O 2 -consuming (7) . Therefore, the active cholesterol synthesis could aggravate hypoxic injury due to further depletion of O 2 . Indeed, a recent report revealed that hypoxia inhibits cholesterol synthesis and that this condition leads to downregulation of HMG-CoA reductase through hypoxia inducible factor-1 (HIF-1)-mediated Insig-1 and Insig-2 induction. Therefore, there seems to be a connection between cholesterol synthesis and HIF-1-mediated hypoxic responses (8) .
HIF-1 is a transcription factor that mediates adaptive responses to hypoxia. It enhances O 2 delivery and promotes cell survival under a low oxygen environment by upregulating numerous genes. In a view of tumor, HIF-1 acts as a tumor-promoting factor because it provides angiogenesis, metastasis and resistance against chemotherapy and radiotherapy (9). HIF-1 is a heterodimer consisting of a hypoxiainducible a subunit and a constitutively expressed b subunit (10) . Of these, HIF-1a functions as the prime transcription factor responsible for gene expression and HIF-1b helps HIF-1a bind to DNA. HIF-1a is upregulated in the posttranslational level through a decrease in protein degradation in response to hypoxia (O 2 -dependent mechanism). HIF-1a is also induced in the translational level, namely, by upregulation of its synthesis in response to growth factor stimulations and subsequent activations of phosphoinositol-3-kinase (PI3K)/Akt/ mammalian target of rapamycin (mTOR) or RAF/mitogen-activated protein kinase kinase (MEK)/mitogen-activated protein kinase (MAPK) pathways (O 2 -independent mechanism) (10). Of several HIF-1a stimuli, EGFR activation in prostate and breast cancers is regarded as a critical process that stimulates HIF-1a protein synthesis and thus promotes cell proliferation and resistance to apoptosis (11) . Especially, the non-hypoxic HIF-1a expression is an important mechanism underlying HIF-1a overexpression and hypervascularity found in some tumors (12) . Therefore, therapeutic agents targeting HIF-1 showed marked effect on tumor growth (10).
Overexpressions of EGFR and HIF-1a have been associated with tumor malignancy and poor prognosis (12, 13) . Signaling events leading to cell transformation and cancer progression are known to be dependent on lipid rafts/caveolae (3). In addition, cholesterol levels have been linked to lipid rafts/caveolae levels on the cell surface (4, 14) . Previously, we have demonstrated that rafts disruption by cholesterol depletion induced anoikis-like cell death via focal adhesion kinase downregulation and rafts internalization and also that EGFR was activated during cholesterol depletion (4, 15) . Given that HIF-1a is expressed via EGFR activation and cholesterol synthesis is regulated by HIF-1a, we could hypothesize that rafts disruption influence HIF1a expression and activity under normoxic conditions. Thus, we examined the effects of cholesterol depletion on HIF-1a and vascular endothelial growth factor (VEGF) expression and investigated the cellular signaling pathway leading to rafts disruption-induced HIF-1a upregulation. We also demonstrated the effect of HIF-1a induction on anoikis-like cell death induced by rafts disruption.
Materials and methods

Cell culture
Human epidermoid carcinoma cell lines, A431 and Hela, human lung carcinoma cell line A549 were obtained from the American Type Culture Collection (Rockville, MD). Dulbecco's modified Eagle's medium, fetal bovine serum (FBS), minimal essential medium, RPMI 1640 with L-glutamine and antibiotic-antimycotic (100Â) were purchased from Gibco Laboratories (Grand Island, NY). A431 and Hela cells were cultured in Dulbecco's modified Eagle's medium, supplemented with 10% FBS and antibiotic-antimycotic (1Â). A549 cells were cultured in RPMI 1640 with L-glutamine, supplemented with 10% FBS and antibiotic-antimycotic (1Â). The cells were grown to $70% confluence and were then serum-starved for 4 h using 0.1% bovine serum albumin in medium before treatment. EPO-Hep3B cells were a kind gift from Dr J.-W. P. (Seoul National University College of Medicine, Korea) and were grown in Minimal Essential Medium containing 10% FBS and antibiotic-antimycotic (1Â).
Antibodies and reagents
Methyl-beta cyclodextrin (MbCD) and water-soluble cholesterol were from Sigma-Aldrich (St Louis, MO). Horseradish peroxidase-conjugated goat antimouse IgG and goat anti-rabbit IgG were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal anti-phospho-Akt (Ser 473), anti-active extracellular signal-regulated kinase 1/2, anti-phospho-stress-activated protein kinase/NH2-terminal-Jun kinase (SAPK/JNK) (Thr183/Tyr185), anti-phosphop38 mitogen-activated protein kinase, anti-phospho Stat3(Tyr705) and antiIjBa were purchased from Cell Signaling Technology (Beverly, MA). Anti-HIF-1a antibody was a kind gift from Dr J.-W. P. (Seoul National University in Korea). Recombinant human EGF and anti-phospho EGFR (Tyr-1068) were purchased from Upstate Biotechnology (Lake Placid, NY). SB203580, U0126, AG1478 and LY294002 were purchased from LC Laboratories (Woburn, MA). PP2, S3I-201, PD153035 and SN50 were obtained from Calbiochem (La Jolla, CA). Annexin V-fluorescein isothiocyanate apoptosis detection kit was from BD Biosciences Pharmingen (San Diego, CA). Immobilon-P polyvinylidene difluoride membranes (0.45 lm) were from Millipore (Bedford, MA). Micro-BCA protein assay reagents were from Pierce (Rockford, IL).
Reverse transcription-polymerase chain reaction Total cellular RNA was isolated with Trizol reagent (Invitrogen, Carlsbad, CA), according to the manufacturer's instructions. Complementary DNA fragments were amplified with the following primer pairs: HIF-1a-5#-GCAGCCA-GATCTCGGCGCGAAC-3#(sense), 5#-CTGTGTCCAGTTAGTTCAAACTG-3# (anti-sense); VEGF-5#-GTATGGCCACCTCCTGTCTT-3#(sense), 5#-GAGTA-GATGGTCCTCGGCTT-3# (anti-sense) and BNIP3-5#-GCTCCTGGGTA-GAACTGCAC-3# (sense), 5#-TCTTCATGACGCTCGTGTTC-3# (anti-sense). Polymerase chain reactions were performed in Unit Block Assembly for PTC DNA Engine system (Alpha TM ) for 28 cycles: 95°C for 30 s, 54°C for 30 s and 72°C for 1 min. Products were analyzed on a 1% agarose gel.
Luciferase assays
Serum-starved Hep3B cells were treated with MbCD and lysed in a lysis buffer (25 mM Tris-phosphate, pH 7.8, 2 mM dithiothreitol, 2 mM 1,2-diaminocyclohexane-N,N,N#,N'-tetraacetic acid, 10% glycerol and 1% Triton X-100) and cells were scraped from dishes. The supernatant was collected after centrifugation at 13 000 r.p.m. for 1 min. Luciferase activity was assayed using Luciferase Assay System (Promega, Madison, WI) according to the manufacturer's instructions. Luciferase activity was measured using VICTOR Light Luminescence counter (Perkin Elmer, Shelton, CT) and the data were normalized based on the same number of cells and expressed as the fold induction over control cells.
Immunoblotting analysis
After washing with ice-cold phosphate-buffered saline (10 mM Na 2 HPO 4 , pH 7.4, 145 mM NaCl and 2.7 mM KCl), cells were lysed with 2Â sodium dodecyl (SDS)-polyacrylamide gel electrophoresis sample buffer (20 mM Tris, pH 8.0, 2% SDS, 2 mM dithiothreitol, 1 mM Na 3 VO 4 , 2 mM ethylenediaminetetraacetic acid and 20% glycerol) and boiled for 5 min. Protein concentration of each sample was determined using a Micro-BCA protein assay reagent as described by the manufacturer. In all, 30 lg of total cellular protein was separated by 10-12% SDS-polyacrylamide gel electrophoresis and then transferred to polyvinylidene difluoride membranes as described before (16) . The membranes were blocked 1 h at room temperature in tris-buffered saline with tween-20 (TBST, 20 mM Tris, pH 8.0, 150 mM NaCl and 0.05% Tween 20) containing either 5% bovine serum albumin (for immunoblotting with anti-phospho-Akt antibody) or 5% nonfat dried milk (for immunoblotting with other antibodies). The membranes were then incubated with the primary antibody for overnight at 4°C, washed three times with TBST, incubated with horseradish peroxidaseconjugated goat anti-mouse IgG or goat anti-rabbit IgG secondary antibodies for 1 h at 37°C and then washed with TBST three times. The labeled proteins were visualized using the enhanced chemiluminescence method. In the instances in which the same membrane was reprobed with a different primary antibody, the membrane was incubated in a stripping buffer (62.5 mM Tris, pH 6.8, 2% SDS and 100 mM dithiothreitol) at 50°C for 10 min, washed extensively, reblocked with 5% nonfat milk and then reprobed with another antibody.
Cell viability
The cells were plated in 96-well plates (5 Â 10 3 cells) and cultured overnight prior to treatment with MbCD or other agents. The effects of the reagents on the cell viability were determined 3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay (Promega) as described in the manufacturer's instruction. Absorbance was measured at 490 nm for MTS assay plate reader from MTX Lab Systems (Vienna, VA).
Cell detachment assay
After MbCD treatment, the plate washed with Dulbecco's modified Eagle's medium twice to remove detached cells. Adherent cells were analyzed by MTS assay. Alternatively adherent cells were harvested and counted.
Live cell imaging Right after MbCD treatment, cell detachment was assessed by live cell imaging using Zeiss Axio observer live cell station (Carl Zeiss MicroImaging, Thornwood, NY) and an Axion Vision camera (Axion Technologies, Houston, TX) for 2 h. During imaging, cells were maintained on a stage heated at 37°C under a 5% CO 2 atmosphere. Images were collected every 120 s and the single images shown were prepared using AxioVision.
VEGF assay VEGF concentrations in the growth medium were measured using a commercially available enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, MN) according to manufacturer's instruction. Absorbance at 450 nm was measured and corrected using the 540 nm reading on a Benchmark Microplate Reader. Data analysis was performed using Microplate Manager III software (Bio-Rad Laboratories, Hercules, CA). A standard curve was generated by plotting absorbance versus VEGF standard concentration using linear and nonlinear regression. The standard curve was linear from 0.015 to 2 ng/ml. Concentration of VEGF in the samples was calculated by interpolation from the standard curve. Total protein was determined for normalizing enzymelinked immunosorbent assay.
Plasmid
The small hairpin RNA (shRNA) plasmid constructs for HIF-1a were constructed in the pL-UGIP (17) . The oligonucleotide sequences that generate double-stranded shRNAs for HIF-1a were adopted as described (18) . Lentiviruses were produced as described previously (17) . In brief, the lentiviral genome containing plasmid (pL-UGIP) was transfected into 293FT cells together with an envelope coding plasmid (VSVG) and vector constructs. Lentivirus was harvested 40 h after infection and concentrated by ultracentrifugation. Titers were determined on 293FT cells as transducing units using serial dilutions of vector stocks. When necessary, drug selections of cells were done with 1 lg/ml puromycin after a 24 h recovery in standard growth medium.
Results and Discussion
Lipid rafts disruption upregulates HIF-1a via EGFR activation To explore a possible association between HIF-1a expression and lipid rafts integrity, we disrupted lipid rafts in A431 cells by cholesterol depletion using MbCD and analyzed HIF-1a levels. HIF-1a protein was noticeably upregulated under normoxic conditions by MbCD treatment in dose-and time-dependent manners ( Figure 1A and B). Cholesterol supplementation after MbCD treatment abolished the HIF-1a induction, which supports that such the MbCD action is attributable to cholesterol depletion ( Figure 1B ). Given that EGFR activation mediates O 2 -independent HIF-1a expression (11) and that cholesterol depletion activates the EGFR through ligand-independent receptor dimerization (14), we investigated whether EGFR activation is involved in the MbCD-induced HIF-1a expression. Cholesterol depletion activated EGFR, as previously reported, and it also stimulated the mitogenactivated protein kinase pathways including extracellular signalregulated kinase, p38 and JNK and Src, but not Akt ( Figure 1C ). Epidermal growth factor (EGF) treatment also increased HIF-1a along with activations of various signaling molecules including Akt ( Figure 1D ). To further elucidate the mechanism of HIF-1a induction, cells were cotreated with MbCD and various kinase inhibitors. EGFR inhibition using two different EGFR inhibitors abolished the MbCD-induced HIF-1a expression (Figure 2A and B) . Previously, it was reported that extracellular signal-regulated kinase 1 and 2 is activated through EGFR in MbCD-treated cells (14) and that HIF-1a can be induced by the EGFR-Akt-mTOR pathway (12) . Thus, we investigated whether these pathways are responsible for HIF-1a induction by rafts disruption. As a result, a MEK inhibitor could block HIF-1a induction in MbCDtreated cells, whereas a PI3K inhibitor failed ( Figure 2C ). In addition, Src and p38 inhibitors negligibly affected the MbCD-induced HIF-1a expression ( Figure 2D ). In contrast, when HIF-1a was induced by EGF treatment, Akt and p38 inhibitors somehow reduced HIF-1a expression (supplementary Figure S1 is available at Carcinogenesis Online).
Proposed mechanism underlying MbCD-induced HIF-1a expression HIF-1a is regulated by oxygen-dependent posttranslational modifications such as prolyl hydroxylation. Under normoxic conditions, HIF-1a is hydroxylated, allowing binding to von Hippel-Lindau protein and the E3 ligase complex that leads to HIF-1a degradation by the ubiquitin/proteosomal pathway. Therefore, HIF-1a is maintained at low levels in normoxia. Under hypoxic conditions, however, the HIF1a hydroxylation is inhibited, and thereby leading to HIF-1a stabilization and accumulation (12) . Although many studies demonstrated a central role of HIF-1a in mammalian oxygen homeostasis, a series of studies reported HIF-1a induction under non-hypoxic conditions (10) . For example, HIF-1a is upregulated by activation of oncogenes such as EGFR, Akt and ERBB2 and by inactivation or loss of tumor suppressor genes such as VHL and PTEN (10) . In addition, EGF, stem cell factor and osteopontin can induce HIF-1a accumulation through the PI3K/Akt and Ras-mitogen-activated protein kinase pathways (13, 19, 20) . The results in our study showed that rafts disruption results in HIF-1a induction in an EGFR-activation dependent manner. However, Akt activation is unlikely to contribute to the MbCDinduced HIF-1a expression because Akt is inactivated in MbCDtreated cells (4,21) ( Figure 1C ) and Akt inhibition failed to prevent the HIF-1a induction ( Figure 2C ).
To examine how HIF-1a is upregulated in MbCD-treated cells, we first examined the messenger RNA (mRNA) levels of HIF-1a and found that HIF-1a is induced at the transcriptional levels ( Figure 3A) . Recent reports showed that HIF-1a mRNA expression can be induced under both hypoxia and growth signaling conditions by signal transducer and activator of transcription 3 (STAT3) or nuclear factor-kappaB (NF-jB) (22, 23) . To test these possibilities, we examined whether MbCD-treatment could activate NF-jB and STAT3. We found that there were inhibitor-jB degradation and STAT3 phosphorylation, indicating that cholesterol depletion possibly causes activation of both NF-jB and STAT3 ( Figure 3B ). Furthermore, both a STAT3 inhibitor ( Figure 3C ) and a NF-jB inhibitor ( Figure 3D ) could decrease HIF-1a induction in MbCD-treated cells. These data indicate that activation of NF-jB and STAT3 could be important for HIF-1a induction. Next, Cholesterol levels control HIF-1a expression to examine whether MbCD induces HIF-1a expression in the protein synthesis step, cells were pretreated with cycloheximide (CHX), a protein synthesis inhibitor or MG132, a proteosome inhibitor. CHX treatment rapidly diminished HIF-1a accumulation, indicating ongoing protein synthesis is important for HIF-1a induction in MbCD-treated cells ( Figure 3E ). We blocked protein synthesis by CHX pretreatment to eliminate basal levels of HIF-1a and permitted protein synthesis by removal of CHX, followed by MbCD treatment in the absence or presence of MG132. As shown in Figure 3F , HIF-1a levels are comparable in MbCD-and MG132-treated cells, respectively, but MbCD and MG132 co-treatment further enhanced HIF-1a accumulation. These data indicate that the HIF-1a accumulation is due to an increase in protein synthesis rather than protein stability. Taken all together, the MbCD-induced HIF-1a expression is regulated in both transcriptional and translational levels, as reported in constitutively active RacG12V expressing cells (22) .
Rafts disruption functionally activates HIF-1 HIF-1 is a heterodimeric transcription factor that transactivates HIF-1 target genes such as VEGF, glucose transporters and enzymes of glycolysis (12) . Nuclear localization of HIF-1a protein is known to be necessary for its transcriptional activation of HIF-1a-regulated genes (9, 12) . Therefore, to examine whether HIF-1a upregulation correlated with its increased activity, we determined nuclear localization of HIF-1a by immunoblotting after cell fractionation and found nuclear translocation of HIF-1a after rafts disruption ( Figure 4A) . Lamin B and a-tubulin were analyzed to verify nuclear and cytosolic fractions, respectively. HIF-1a activation leads to an increased transcription of a number of different genes including VEGF in response to non-hypoxic stimuli as well as hypoxia (9) . To test whether HIF-1a activation by rafts disruption results in an increase of VEGF mRNA, total cellular RNA extracts were processed for reverse transcriptionpolymerase chain reaction for VEGF mRNA. Interestingly, rafts disruption induced VEGF transcription much greater than that of hypoxia ( Figure 4B ). In these experiments, because we treated cells with MbCD for 4 h, we included the sample of a 4 h-hypoxic conditions as a positive control for HIF-1a induction. We also examined another protein BNIP3 that is upregulated by HIF-1a (24) . As illustrated in Figure 4B , BNIP3 expression was slightly increased upon MbCD treatment. To further investigate whether this VEGF mRNA upregulation correlates with VEGF protein levels, cell culture supernatant was collected after MbCD treatment and VEGF levels were Fig. 4 . HIF-1a activity in MbCD-treated cells. (A) Serum-starved A431 cells were treated with 5 mM MbCD and then fractionated to obtain cytosol and nuclear fractions. Each fraction was subjected to immunoblotting analysis using HIF-1a, Lamin B and a-tubulin antibodies. (B) Serum-starved A431 cells were treated as in (A) and total RNA was extracted and subjected to reverse transcription-polymerase chain reaction to assess VEGF mRNA levels and BNIP3 mRNA levels. The levels of BNIP3 were quantified by densitometry and normalized with b-actin. The ratio of BNIP3 to the total b-actin in the control cells was set as 1. (C) After cells were treated as indicated, VEGF contents in supernatants were determined by enzyme-linked immunosorbent assay as described in the 'Materials and Methods'. Data are expressed as the mean of triplicate ± SD; Ã , statistically significant difference as compared with the control (P , 0.001). ÃÃ , statistically significant difference as compared with the 3 mM 7 h (P , 0.001). (D) Serum-starved EPO-HEP3B cells were treated with 3 mM MbCD for 7 h and cell lysates were analyzed by immunoblotting using anti-HIF-1a antibodies. The levels of HIF-1a were quantified by densitometry and normalized with b-actin. The ratio of HIF-1a to the total b-actin in the control cells was set as 1. (E) After treatments, EPO-HEP3B cells were lysed and luciferase activity was measured as described in the 'Materials and Methods'.
Ã , statistically significant difference as compared with the control (P , 0.001). (F) Serum-starved HeLa and A549 cells were treated with 5 mM MbCD for 3-5 h and HIF-1a expression was detected by immunoblotting. These data are representative of at least three independent experiments.
Cholesterol levels control HIF-1a expression measured using enzyme-linked immunosorbent assay. Consistent with the data in Figure 3B , VEGF secretion was enhanced by rafts disruption ( Figure 4C ). EGFR activation and subsequent PI3K/Akt activation pathway has been reported to be critical for both hypoxic and non-hypoxic HIF-1a induction (10, 12) . Because we observed that EGFR activation was critical for the HIF-1a induction (Figure 2) , we further examined whether EGFR and MEK are involved in the MbCD-induced VEGF secretion. Both EGFR and MEK inhibitors significantly attenuated the MbCD-induced VEGF secretion ( Figure  4C ). We also examined the effect of rafts disruption on HIF-1 activity in another cell line, Hep3B (EPO-Luc) which is a stable transfectant harboring the EPO-enhancer-luciferase plasmid. MbCD treatment induced HIF-1a upregulation ( Figure 4D ) and increased luciferase activity in the Hep3B cell line ( Figure 4E ). In addition, we could observe the similar effects of MbCD on HIF-1a expression in HeLa and A549 cell lines, indicating that the MbCD-induced HIF-1a induction is not limited to A431 cells ( Figure 4F) . A recent study has demonstrated that non-hypoxic HIF-1a induced by proteosome inhibition is functionally inactivated (25) , indicating that HIF-1a expression and function can be differentially regulated. However, in the present case, rafts disruption not only accumulates HIF-1a but also activates its transcriptional function.
HIF-1a expression attenuates rafts disruption-induced anoikis
Although cholesterol depletion results in ligand-independent EGFR activation (14) , the consequence of its activation has not been addressed. Since EGFR activation is linked to integrin function (26) and rafts disruption enhances cell detachment (4,15), we examined the effect of EGFR inhibition on cell adhesion in cholesteroldepleted cells. Although AG1478 alone affects adhesion a little, the co-treatment of AG1478 and MbCD synergistically enhanced cell detachment compared with MbCD alone ( Figure 5A ). Next, we analyzed EGFR activity and HIF-1a levels in the detached and the attached cells after MbCD treatment. Compared with the detached cells, both EGFR activity and HIF-1a levels were higher in the attached cells ( Figure 5B ) and HIF-1a mRNA was also increased (supplementary Figure S2 is available at Carcinogenesis Online).
To further investigate whether HIF-1a expression is associated with cell adhesion, we reduced HIF-1a expression using shRNA and the HIF-1a reduction was confirmed in HIF-1a-specific shRNA (shHIF1a) cells with MbCD treatment ( Figure 5C ). To test the effect of HIF1a downregulation on cell adhesion in MbCD-treated cells, cell morphological changes were examined by time-lapse analysis. As shown in Figure 5D , rafts disruption accelerated cell detachment in shHIF-1a cells and consistently, more cells were detached in the MbCD-treated shHIF-1a cells compared with shRNA empty vector cells ( Figure 5E ). HIF-1a has been implicated as a mediator of cancer cell migration, invasion and metastasis. HIF-1a increases cell adhesion by inducing syndecan-4 and a5-integrin in various cell types (27, 28) . A recent report also discussed that HIF-1a-deficient gastric cancer cells are defective in cell migration, invasion and adhesion to endothelial cells (29) . Therefore, it is possible that HIF-1a induction might regulate adhesion-related molecules, leading to sustained cell adhesion in the MbCD-treated cells.
Accumulating evidence has demonstrated that HIF-1a is induced by non-hypoxic stimuli but understanding of HIF-1a's role is in various non-hypoxic conditions remains incomplete. Recently, it is believed that HIF-1a induction by growth factors such as EGF and insulin-like growth factor-1 and osteopontin contribute to cell proliferation and survival (9, 20, 30) . Previously, we demonstrated that rafts disruption decreases cell adhesion and causes detachmentinduced cell death known as anoikis (4, 15) . Because HIF-1a expression has been linked to cell survival, we examined whether HIF-1a expression affect anoikis-like cell death by apoptosis analysis. Consistent with the adhesion data showing that knockdown of HIF-1a by RNA interference (shHIF-1a cells) resulted in increased cell detachment by MbCD, inhibition of HIF-1a expression augmented anoikislike cell death induced by MbCD ( Figure 5F ). These data indicate that rafts disruption by cholesterol depletion induces HIF-1a upregulation, which in turn provides the resistance to detachment-induced cell death. More recently, Rohwer et al. (29) demonstrated that HIF-1a mediates anoikis resistance via suppression of a5-integrin, which is supportive to our finding that HIF-1a downregulation accelerates anoikis induced by rafts disruption.
Cholesterol synthesis is an oxygen-consuming process and thus during hypoxia cholesterol synthesis is known to be inhibited due to downregulation of HMG-CoA reductase. HIF-1a expression mediates HMG-CoA reductase repression by inducing Insig-1 and Insig-2, which are involved in HMG-CoA reductase degradation (8) . Because cholesterol is a critical lipid component for rafts structure (2), hypoxia could modulate rafts. Recent data have demonstrated that a mild degree of hypoxia triggers a significant remodeling of the lipid microdomains (31). Therefore, it is possible that hypoxia regulates and/or modifies lipid rafts to facilitate adaptation to the hypoxic conditions because lipid rafts are important for cellular signalings for cell survival, migration and invasion.
Statins, HMG-CoA reductase inhibitors, are cholesterol-lowering drugs (32) . Reports by our group and Freeman group have demonstrated that cholesterol depletion using either simvastatin or MbCD decreases cell surface levels of lipid rafts and inactivates rafts/caveolae-mediated signalings such as Akt activity (4, 33) . Interestingly, pravastatin and simvastatin can induce HIF-1a expression and VEGF expression in endothelial cells in normoxia although a possible underlying mechanism for HIF-1a induction was missing (34, 35) . Our present study demonstrated that acute cholesterol depletion using MbCD induces HIF-1a upregulation through EGFR activation and further illustrated that HIF-1a induction is important for anoikisresistance. Therefore, it is possible that cholesterol depletion using MbCD could be similar to long-term statin treatment. Recently, studies show anticancer effects of statins (32) but it is possible that HIF-1a induction in response to cholesterol depletion could have a protective effect from cytotoxicity in some cases, which should be elucidated in detail by future works.
In summary, our study demonstrated that HIF-1a is induced in response to cholesterol depletion/rafts disruption via EGFR activation and surprisingly, HIF-1a expression is critical for prevention from anoikis-like cell death. Clearly, extensive work is required to elucidate a role of HIF-1a in anoikis regulation in relation to lipid rafts. Nevertheless, our data suggest a connection between HIF-1 and lipid rafts integrity/cholesterol levels, both of which are potential targets for cancer treatment.
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